Incorporating Innovative B-Cell Targeting Therapeutics into a
Combined-Modality Bridging Approach Followed by Timely Consolidative
Haploidentical Transplantation to Salvage a Pediatric Patient with
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Yu-Ju Chao
, - Pei-Ing Lee,
- Tzu-Hsien Yang,
- Li-Hua Fang,
- Yu-Chun Tsai,
- Ming-Yuan Lee,
- Yun-Hsin Wang,
- Liuh-Yow Chen
, - Rong-Long Chen
Tzu-Hsien Yang
Institute of Molecular Biology Academia Sinica
Author ProfileLiuh-Yow Chen
![](https://d197for5662m48.cloudfront.net/assets/icons/omniauth/orcid-ca37582cd91a671ed5cec57770e0e96c01b4b79b8b5b75d8598fc1ddac18c974.svg)
Institute of Molecular Biology Academia Sinica
Author Profile09 Aug 2024Submission Checks Completed 09 Aug 2024Assigned to Editor
09 Aug 2024Submitted to Pediatric Blood & Cancer 09 Aug 2024Review(s) Completed, Editorial Evaluation Pending
12 Aug 2024Editorial Decision: Accept